Iron Pillar, Kalaari & Navam-backed Vyome set for NASDAQ debut with reverse merger

Premium

Vyome Therapeutics Inc, a clinical-stage healthcare company targeting immunoinflammatory and rare diseases in the US and other global markets, has inked an agreement to merge with an arm of an existing NASDAQ-listed healthcare company via a virtual reverse merger that would open up a window for an exit in the ......